KalshiOpen

When will the FDA approve Intellia Therapeutics' lonvo-z?: When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema? Before July 2027

Before July 202793%

No7%

Price checked at Sep 29, 09:47 PM UTC

Trade

Set your country to see where you can trade.Set your country →

Opens the venue in a new tab, through Predxy.

24h volume$2.1

7d volume—

30d volume—

Liquidity—

Spread5%

ResolvesJan 1, 2028next year

Probability history

Market-implied probabilities · All recorded history

Drag to move · pinch or ⌘/Ctrl+scroll to zoom

Shaded periods have no successful hourly price check.

Based on this market’s outcome prices, expressed as probabilities.

If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.

A leg read alone is misleading; the others are beside it.

Market	Venue	Price	24h volume	Liquidity	Scheduled end	Status
When will the FDA approve Intellia Therapeutics' lonvo-z?: When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema? Before 2028	Kalshi	72% Before 2028	$0	—	—	Open
When will the FDA approve Intellia Therapeutics' lonvo-z?: When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema? Before October 2027	Kalshi	87% Before October 2027	$0	—	—	Open

Read from the venue this minute

Holders—

Held value—

Trades (24h)—

Trades—

Open interest—

Comments0

What Predxy's readers make of this market. Everyone can read; signed-in readers can write. The venue's own thread, when it has one, is the box below.

Nobody has said anything here yet.

As of Sep 29, 10:14 PM UTC